BayWa's Restructuring Faces April Reckoning Amid Governance and Reporting Void

BayWa faces a critical liquidity test, delayed financials, and a EUR 2.7B restructuring shortfall. Creditor talks and asset sales like T&G Global are key to survival.

Investors in German agricultural conglomerate BayWa are navigating in the dark. The company has postponed its audited annual and group financial statements for 2025, with publication now not expected until the fourth quarter of 2026. This blackout deprives shareholders of any reliable basis for valuation, a uncertainty reflected in a 4.1% share price drop to EUR 12.85. The stock, now at EUR 13.40, trades roughly 38% below its 52-week high and has lost a fifth of its value since the start of the year.

The immediate focus, however, is a critical liquidity test. By the end of April, BayWa must secure EUR 107 million. This sum is expected from the sale of its grain trading subsidiary Cefetra, comprising EUR 45 million from the purchase price and EUR 62 million from the repayment of shareholder loans.

These funds are far more than a cash injection; they are essential bargaining chips. The money is intended to persuade the company's two main creditors, DZ Bank and HVB, to extend a standstill agreement until autumn 2026. Without this extension, a restructuring plan finalized under Germany's StaRUG insolvency law in May 2025 would lose its legal foundation, leaving management with no operational basis to continue the corporate overhaul.

The broader restructuring effort, aimed at raising EUR 4 billion from asset sales by 2028, is severely off track. Only EUR 1.3 billion has been secured so far, leaving a staggering EUR 2.7 billion gap after a planned partial sale of the energy subsidiary BayWa r.e. collapsed due to missing US subsidies.

As a next major step, BayWa launched the sale process for its New Zealand-based fruit trading subsidiary T&G Global in March 2026. Goldman Sachs is marketing BayWa's nearly 74% stake. T&G, which returned to profitability with a net income of USD 16 million on USD 1.3 billion in revenue in 2024, is not a distressed asset. Specialized agricultural investors like Roc Partners, Paine Schwartz, and Hancock are seen as potential buyers, with an expected proceeds of around EUR 300 million. The process is complicated by Hong Kong-based minority shareholder Joy Wing Mau Group, which holds nearly 20% and whose stance remains unclear.

Pressure is mounting on BayWa's ownership structure. Cooperative banks have already written off 60% of a EUR 220 million bond loan. GVB association president Stefan Müller anticipates further write-downs due to delays in the restructuring plan, with around EUR 200 million still at risk for the Bavarian primary banks.

Simultaneously, the company's supervisory board is thinning. Monika Hohlmeier and Michael Höllerer departed at the end of March, with Monique Surges set to follow at the end of May. No successors have been named. In response to earlier control deficits, the remaining board members have lowered the approval threshold for transactions from EUR 200 million to EUR 50 million.

Operationally, management has prescribed a harsh austerity course. BayWa is now focusing on four core business areas and cutting approximately 1,300 jobs. The company has also sharply scaled back its profit targets. The adjusted EBITDA goal for 2027 has been reduced to around EUR 140 million, down from an original target of EUR 230 million by 2028. The financial forecast for 2026 has been withdrawn entirely.

All converging timelines point to a decisive moment in the final quarter of 2026. By then, the delayed audited financial statements and a crucial bank agreement are supposed to be in place. Neither milestone is currently assured, setting the stage for a final test of the embattled group's survival.